About the Institute
The IDOM was established in 2005 by the Dean of the School of Medicine, at a time of ever increasing prevalence of diabetes and obesity. In the United States alone, there are currently 20.6 million people with diabetes and 58 million obese. In 2000, the cost of diabetes was estimated at $132 billion per year, and the Centers for Disease Control has projected that one out of three children born in the year 2000 will develop diabetes in his or her lifetime.
The mission of the IDOM is to support and develop successful approaches to the prevention, treatment, and cure of diabetes mellitus and obesity.
The leadership of the IDOM embraces a disease-oriented approach that focuses on Type 1 diabetes, Type 2 diabetes, Obesity, and Cardiovascular Complications. IDOM enhances and supports research aimed at understanding the genetic, biochemical, molecular, environmental, and behavioral mechanisms underlying diabetes and obesity. IDOM initiatives include critical and unique scientific core facilities, and pilot grants that support new investigators as well as interdisciplinary science involving investigators from Penn Medicine and throughout the University of Pennsylvania that are relevant to the IDOM mission. IDOM also fosters education by organizing a series of seminars, workshops, and symposia. We are proud of the many outstanding discoveries made by IDOM investigators, and are committed to the translation of this new knowledge into novel approaches to patient care. The IDOM is home to the prestigious Diabetes and Endocrinology Research Center. We are also grateful for philanthropy to support of our mission.
The IDOM creates a unique and exciting environment within a great university and prominent health system. I invite you to explore this web site and learn more about us.
Mitchell A. Lazar, M.D., Ph.D.